Posted on

Covid-19: Boosters, Antibodies, and Continued Risk for the Immunocompromised

Loading

World-leading specialist shares latest information on Covid-19 in transplant patients

On February 24th, CareDx hosted a webinar with NYU’s Dr. Dorry Segev, one of the world’s leading experts on the impact of Covid-19 on immunocompromised patients. When the pandemic hit, Dr. Segev shifted his research to better understanding vaccines in the immunocompromised, for which he has received a Letter of Commendation from Dr. Anthony Fauci. His research has been published in JAMA, and featured on CBS, NBC, NPR, and the New York Times, among other publications. In recognition of his contributions to health care, Dr. Segev was recently elected to the National Academy of Medicine.

We adapted our webinar conversation with Dr. Segev for this article, editing only for clarity and length. Read the full article here.

Loading
Posted on

Nephrologists see regulatory, legislative wins, more work ahead

Loading

DALLAS — After uncertainty a year ago from a leadership void at HHS, nephrology practices and kidney research are seeing benefits from recent legislative and regulatory victories, according to a speaker at the Renal Physicians Association Annual Meeting.

“A year ago, we were in the early days of the Biden Administration,” Robert Blaser, director of public policy for the RPA, said, here. “There was a lot of uncertainly this time last year.”
Read more.

Loading
Posted on

Transplant waiting list

Loading

If you need a kidney transplant, you will need to get on the national transplant waiting list for a deceased donor kidney. Learn how the waiting list works, how long people usually wait and how to choose a transplant center so you can get listed. You can take steps to stay as healthy as possible while you wait for a kidney. Learn more.

Loading
Posted on

Living Donor Transplant Promising for CRC With Liver-Only Metastases

Loading

— In small study, researchers see “encouraging” survival outcomes

Select patients with unresectable colorectal cancer liver metastases (CRLMs) had good survival outcomes following total hepatectomy and living-donor liver transplant (LDLT), a prospective study of 10 patients found.

In the series involving liver-confined metastatic disease in patients with a sustained response to oncologic therapy, Kaplan-Meier estimates of recurrence-free and overall survival at 1.5 years were an “encouraging” 62% and 100%, respectively, reported Gonzalo Sapisochin, MD, PhD, of the University of Toronto, and colleagues. Read more.

Loading
Posted on

She gave her kidney to a high school acquaintance — and it changed his life

Loading

John “JT” Thomas was a healthy 20-year-old in 2011. But at that year’s family Thanksgiving gathering, he found that he couldn’t even finish his first plate of food. His appetite was gone — and he was increasingly lightheaded.

His physicians had a chilling response to his symptoms, one that he recalls even today: “You shouldn’t be able to walk right now.” Read the full story here.

Loading
Posted on

Cleveland Clinic experts join call to end disparities in organ donation; African-Americans face barriers to transplant list

Loading

CLEVELAND, Ohio — African-Americans and rural Americans often face barriers that keep them off organ transplant waiting lists, according to a new report from the National Academies of Sciences, Engineering and Medicine.

The Cleveland Clinic’s Dr. James Young and Jesse Schold were among the experts involved in drafting the recently announced recommendations. Read more.

Loading
Posted on

Mediterranean diet may preserve kidney function better than low-fat for adults with CHD

Loading

Adults with coronary heart disease who followed a Mediterranean diet preserved their kidney function better than those who followed a low-fat diet for 5 years, according to study data published in Clinical Nutrition.

“In persons suffering from coronary heart disease and, in combination with type 2 diabetes, the long-term consumption of a Mediterranean diet would be recommended to preserve kidney function,” Jose LopezMiranda, MD, PhD, professor of internal medicine at the University of Cordoba and director of the internal medicine unit at Reina Sofia University Hospital in Spain, and Elena M. Yubero-Serrano, PhD, emerging researcher at the Maimonides Biomedical Research Institute of Cordoba, told Healio. “Besides the pharmacological treatment for these diseases, recommendation to follow this dietary model could reduce and delay kidney complications.” Read more.

Loading
Posted on

Thorough evaluation key in identification of candidates for home dialysis, transplant

Loading

PHOENIX — Successful transition from chronic kidney disease to either home dialysis or transplantation requires a thorough evaluation of a patient’s psychosocial and economic status, speakers said at the Southwest Nephrology Conference.

“The role of the social worker is vital to the stability of a patient on a home modality,”Lauren Pelletier, MSW, CCM, a social worker for patients on peritoneal dialysis at DaVita Inc. “Psychosocial status impacts a patient’s ability to adhere to treatment,” she said. “As social workers, we can assist patients with emotionally adjusting to dialysis,” Pelletier said. Read more.

Loading
Posted on

HISTORY IN THE OR: FIRST ALL-FEMALE LIVER TRANSPLANT TEAM AT MICHIGAN MEDICINE CARRIES OUT LIFE-SAVING PROCEDURE

Loading

MICHIGAN MEDICINE HEADLINES> OUR EMPLOYEES

HISTORY IN THE OR: FIRST ALL-FEMALE LIVER TRANSPLANT TEAM AT MICHIGAN MEDICINE CARRIES OUT LIFE-SAVING PROCEDURE

March 28, 2022  //  FOUND IN: Our Employees, Top Story

At first glance, it looked just like another liver transplant surgery at Michigan Medicine. There were surgeons, fellows, anesthesiologists, scrub nurses and more crowded into the operating room, prepping the patient and carrying out the hours-long procedure.

But this was no ordinary surgery. Read the full story.

Loading